
The healthcare market is evolving due to technological advancements and global health challenges, with increasing demand for innovative solutions driven by aging populations, chronic conditions, and the shift toward value-based care.
Given this backdrop, it could be wise to consider investing in fundamentally strong healthcare stocks, Immunocore Holdings plc (IMCR), Catalyst Pharmaceuticals, Inc. (CPRX), and BioCryst Pharmaceuticals, Inc. (BCRX), that tackle rare diseases.